Midsummer Madness: EMA Headquarters Rumors Fly At BIO
Executive Summary
The biotech industry's annual confab, already known as a stage for countries and regions to play up their potential as industry hubs, is now the venue for rumors over who will host the headquarters for the European Medicines Agency post-Brexit.
You may also be interested in...
Criteria Out For EMA’s Future Home; Bid Procedure About To Be Approved
The procedure allowing EU member states to bid to host the European Medicines Agency when it leaves the UK is to be formally endorsed by a meeting of heads of state on June 22. The criteria countries will have to meet have been publicly announced at a press conference following a meeting of EU ministers.
AI Firm Healx Raises $56M To Develop Affordable Rare Disease Treatments
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.
Abalos Raises €12M Series A To Develop Arenavirus-Based Cancer Therapies
Tapping into the ability of arenaviruses to deliver prolonged local immune activation, rapid regression of localized and metastatic cancers, and long-term disease control, Essen, Germany-based start-up Abalos Therapeutics has raised €12m to advance its lead candidates towards clinical testing.